Results 111 to 120 of about 5,298,587 (157)

Incidental Intense Fibroblast Activation Protein Inhibitor (FAPI) Uptake in Bilateral Gluteal Myositis Ossificans: A Case Report. [PDF]

Cureus
Al-Rashdan R, Ruzzeh S, Al-Hajaj N, Al-Rasheed U, Al-Ibraheem A.   +4 more
europepmc   +1 more source

⁶⁸Ga-labeled fibroblast activation protein inhibitor (FAPI) PET/CT for locally advanced or recurrent pancreatic cancer staging and restaging after chemoradiotherapy. [PDF]

Theranostics
Metzger G, Bayerl C, Rogasch JM, Furth C, Wetz C, Beck M, Mehrhof F, Amthauer H, Ghadjar P, Neumann C, Pelzer U, Zips D, Hofheinz F, Grabowski J, Schatka I, Zschaeck S.   +15 more
europepmc   +1 more source

Predictive performance of [¹⁸F]F-fibroblast activation protein inhibitor (FAPI)-42 positron emission tomography/computed tomography (PET/CT) in evaluating response of recurrent or metastatic gastrointestinal stromal tumors: complementary or alternative to [¹⁸F]fluorodeoxyglucose (FDG) PET/CT? [PDF]

Quant Imaging Med Surg
Wu C, Wen F, Lin F, Zeng Y, Lin X, Hu X, Zhang X, Zhang X, Wang X.   +8 more
europepmc   +1 more source

Clinical characterisation and therapeutic insights from a single-centre cohort of seven patients with Gorham-Stout disease. [PDF]

BMJ Open Respir Res
Li N, Le X, Xu D, Zeng Y, Wang X, Wang J, Hao Z.   +6 more
europepmc   +1 more source

Evaluating [¹⁸F]-AlF-FAPI-74 PET/CT for diagnosis of the unfavourable CMS4 colorectal cancer subtype (FoCus study): protocol for a prospective, observational, proof-of-concept clinical study. [PDF]

BMJ Open
van Duijvenvoorde M, Kranenburg O, van den Bos M, Hagendoorn J, Roodhart JML, Milne AN, Te Riele WW, Lange MM, Swijnenburg RJ, Arensman R, Verheijen PM, Schiphorst AHW, Kool W, Ververs T, De Keizer B, Lacle MM, Lam MGEH, Elias SG.   +17 more
europepmc   +1 more source

Comments on "Prognostic Significance of Pretreatment [¹⁸F]ALF-NOTA-FAPI-04 PET/CT in Patients With Recurrent Gastric Cancer Undergoing Combined PD-1 Inhibitor and Chemotherapy". [PDF]

Korean J Radiol
Liu H, Liu X.
europepmc   +1 more source

Advances in Positron Emission Tomography Combined With Computed Tomography (PET/CT) Imaging in Cervical Cancer: From Metabolic Assessment to Fibroblast Activation Protein-Targeted Imaging. [PDF]

Cureus
Usmani S, Ahmed N, Burney IA, Kheruka S, Numani SP.   +4 more
europepmc   +1 more source

Comparative Performance of ¹⁸F-FDG PET/CT and ⁶⁸Ga-FAPI PET/CT in TENIS Syndrome in Treated Differentiated Thyroid Carcinoma. [PDF]

Mol Imaging Radionucl Ther
Bhagirath Bhad J, Sarma M, Menon U, R R, Pavithran P, Saxena A, Sajeev S, B. Reddy VSR, Subramanyam P, Sundaram PS.   +9 more
europepmc   +1 more source

The Role of ⁶⁸Ga-FAPi PET/CT in Staging and Restaging of Breast Cancer Subtypes with Limited ¹⁸F-FDG Uptake. [PDF]

Mol Imaging Radionucl Ther
Beydağı G, Alan Selçuk N, Akçay K, Görmez A, Köksal N, Çelik S, Öven BB, Kabasakal L.   +7 more
europepmc   +1 more source

Per-patient Comparison of [⁶⁸Ga]-FAPI-46 Versus [¹⁸F]FDG as PET Tracers in ER-positive Breast Cancer: Study Design of a Single-centre Prospective Study. [PDF]

J Cancer
Lenaerts M, Duijx LEHW, Mottaghy FM, Bauwens M, van Geel RMJM, Tjan-Heijnen VCG, Backhaus P, Kooreman LFS, Nelemans PJ, Smidt ML, Wildberger JE, van Nijnatten TJA.   +11 more
europepmc   +1 more source